To explore the mechanism by which TRF alleviated NASH, we discerned that TRF not only inhibited the expression of Per2 but also significantly inhibited ferroptosis—with reduced LPO levels, attenuated expression of ferroptosis-related genes, and the remission of morphologic changes in mitochondria. The gene discussed is PER2; the disease is metabolic dysfunction-associated steatohepatitis.